glp-1 impulse control therapy appears to reduce binge eating type behaviours in people with obesity, based upon this recently published systematic review and meta-analysis eClinicalMedicine, 2026, 104007, ISSN 2589-5370 GLP-1 | Summary
Description
Registration clinical trials show that 16-37% of patients discontinue within a year (109111)
How does Canada perform in the GLP-1 Aftercare & Metabolic Continuity Services Market
Sig Transduct Target Ther, 2024, Vol 9, (1), p 234
2024;59:S52S75
Next Steps if Youre Interested in Foundayo If you think Foundayo might be right for you, start by talking with your healthcare provider
With a medically guided weight loss plan, you can lose stubborn weight, boost your energy, and gain the tools to maintain your results for good
